Veradigm (NASDAQ:MDRX) Sees Large Volume Increase – Time to Buy?

Veradigm Inc. (NASDAQ:MDRX) saw unusually-high trading volume on Wednesday . Approximately 424,727 shares changed hands during mid-day trading, an increase of 172% from the previous session’s volume of 156,230 shares.The stock last traded at $4.90 and had previously closed at $4.95.

Analysts Set New Price Targets

Separately, Wall Street Zen raised shares of Veradigm to a “hold” rating in a research report on Saturday, March 7th.

Veradigm Stock Performance

The company’s 50-day moving average is $4.75 and its 200 day moving average is $4.66. The company has a market capitalization of $623.73 million, a PE ratio of 23.25 and a beta of 0.55.

About Veradigm

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.